查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1692204

尼古丁替代療法市場 - 全球產業規模、佔有率、趨勢、機會與預測，按產品、配銷通路、地區和競爭細分，2020-2030 年

Nicotine Replacement Therapy Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product, By Distribution Channel, By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球尼古丁替代療法市場價值為 538 億美元，預計在預測期內將實現強勁成長，到 2030 年的複合年成長率為 8.20%。全球尼古丁替代療法 (NRT) 市場是戒菸產品和服務領域中一個充滿活力且不斷發展的產業。它在幫助人們戒菸和克服尼古丁成癮方面發揮關鍵作用。 NRT 市場涵蓋一系列旨在幫助個人戒菸或使用菸草製品的產品和療法。這些產品提供控制劑量的尼古丁，但不含香菸中的有害毒素，以減輕戒斷症狀和菸癮。 NRT 產品有多種形式，包括尼古丁口香糖、貼片、含片、吸入器、鼻腔噴霧劑和處方藥。

市場概況
預測期 2026-2030
2024 年市場規模 538億美元
2030 年市場規模 865.2 億美元
2025-2030 年複合年成長率 8.20%
成長最快的領域 電子煙
最大的市場 北美洲

主要市場促進因素

健康意識的提高和吸煙的有害影響

主要市場挑戰

監管障礙和嚴格核准

主要市場趨勢

電子商務和遠距醫療服務的採用日益增多

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：顧客之聲

第 5 章：尼古丁替代療法市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依產品（尼古丁替代療法（吸入器、口香糖、經皮貼片、舌下片、含片等）、電子煙、加熱不燃燒菸草產品）
    • 按配銷通路（線下、線上）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第 6 章：北美尼古丁替代療法市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 加拿大
    • 墨西哥

第 7 章：歐洲尼古丁替代療法市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 英國
    • 義大利
    • 法國
    • 西班牙

第 8 章：亞太地區尼古丁替代療法市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 印度
    • 日本
    • 韓國
    • 澳洲

第 9 章：南美洲尼古丁替代療法市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲尼古丁替代療法市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 最新動態
  • 產品發布
  • 合併與收購

第 13 章：全球尼古丁替代療法市場：SWOT 分析

第 14 章：競爭格局

  • Cipla Inc.
  • Pfizer Inc.
  • Johnson & Johnson Services, Inc.
  • Philip Morris Products SA
  • British American Tobacco plc
  • Japan Tobacco, Inc.
  • Imperial Brands PLC
  • Glenmark Ltd

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 17578

Global Nicotine Replacement Therapy Market was valued at USD 53.80 Billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 8.20% through 2030. The Global Nicotine Replacement Therapy (NRT) Market is a dynamic and evolving sector within the broader landscape of smoking cessation products and services. It plays a pivotal role in helping individuals quit smoking and overcome nicotine addiction. The NRT market encompasses a range of products and therapies designed to assist individuals in quitting smoking or using tobacco products. These products deliver controlled doses of nicotine, without the harmful toxins found in cigarettes, to reduce withdrawal symptoms and cravings. NRT products are available in various forms, including nicotine gum, patches, lozenges, inhalers, nasal sprays, and prescription medications.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 53.80 Billion
Market Size 2030USD 86.52 Billion
CAGR 2025-20308.20%
Fastest Growing SegmentE-cigarettes
Largest MarketNorth America

Key Market Drivers

Rising Health Awareness and the Harmful Effects of Smoking

The increasing awareness of the health risks associated with smoking is a primary driver of the Global Nicotine Replacement Therapy (NRT) Market. As consumers become more informed about the dangers of tobacco use, demand for effective smoking cessation solutions continues to rise. This shift in consumer behavior, coupled with public health initiatives and regulatory support, is creating a strong market environment for NRT products such as nicotine patches, gums, lozenges, inhalers, and nasal sprays. According to the American Heart Association (AHA), smoking-related diseases are responsible for over 440,000 deaths annually in the United States. A significant concern is that the majority of new smokers are children and adolescents, highlighting a critical public health challenge. Smoking significantly elevates the risk of severe health conditions, including lung diseases such as lung cancer and emphysema, as well as cardiovascular diseases like heart disease and stroke. Public health campaigns, scientific studies, and widespread media coverage have significantly increased consumer awareness of the adverse effects of smoking. Tobacco use has been linked to a range of serious health conditions, including Smoking contributes to high blood pressure, heart attacks, and strokes. Smoking is a major contributor to cardiovascular disease, accounting for 20% of all smoking-related deaths. The risks are even more pronounced for women over 35 who smoke while taking oral contraceptives, as they face a significantly higher likelihood of heart disease, stroke, and blood clots. Additionally, cigarette smokers are 2 to 4 times more likely to develop heart disease compared to nonsmokers, creating a substantial burden on healthcare systems and workplace productivity.

Key Market Challenges

Regulatory Hurdles and Stringent Approvals

One of the primary challenges facing the NRT market is the lack of uniform regulations governing the sale and distribution of NRT products worldwide. Each country has its own regulatory framework, which can create complications for manufacturers trying to expand globally. Variances in regulations can lead to delays in product approvals and market entry.

NRT products often require rigorous clinical trials and safety assessments for regulatory approval. These processes can be time-consuming and costly. Delays in approvals can hinder the introduction of new and innovative NRT products, slowing market growth. The tobacco industry is a powerful entity with significant influence in some regions. It may lobby against NRT products as they can potentially reduce smoking rates. This lobbying can result in stricter regulations or negative public perceptions of NRT, hindering market growth.

In some cases, NRT products are erroneously categorized as tobacco products, subjecting them to tobacco-related regulations and taxes. This misclassification can increase costs for both manufacturers and consumers, making NRT less accessible.

Key Market Trends

Increasing Adoption of E-Commerce and Telehealth Services

The rise of e-commerce and telehealth services has transformed the way consumers access NRT products and smoking cessation support. E-commerce platforms provide a convenient and discreet way for individuals to purchase NRT products without visiting physical stores. Telehealth services offer remote consultations with healthcare professionals who can prescribe NRT products and provide personalized guidance for quitting smoking.

This trend has significantly expanded the reach of NRT products, making them more accessible to a broader audience. It has also enhanced user convenience, particularly during the COVID-19 pandemic when in-person visits to healthcare facilities were limited. As telehealth becomes more mainstream, it is likely to drive continued growth in the NRT market.

Key Market Players

  • Cipla Inc.
  • Pfizer Inc.
  • Johnson & Johnson Services, Inc.
  • Philip Morris Products S.A
  • British American Tobacco p.l.c.
  • Japan Tobacco, Inc.
  • Imperial Brands PLC
  • Glenmark Ltd

Report Scope:

In this report, the Global Nicotine Replacement Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Nicotine Replacement Therapy Market, By Product:

  • Nicotine Replacement Therapy (Inhalers, Gum, Transdermal Patches, Sublingual Tablets, Lozenges, Others)
  • E-cigarettes
  • Heat-not-burn Tobacco Products

Nicotine Replacement Therapy Market, By Distribution Channel:

  • Offline
  • Online

Nicotine Replacement Therapy Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Nicotine Replacement Therapy Market.

Available Customizations:

Global Nicotine Replacement Therapy market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Nicotine Replacement Therapy Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Nicotine Replacement Therapy (Inhalers, Gum, Transdermal Patches, Sublingual Tablets, Lozenges, Others), E-cigarettes, Heat-not-burn Tobacco Products)
    • 5.2.2. By Distribution Channel (Offline, Online)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Nicotine Replacement Therapy Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Distribution Channel
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Nicotine Replacement Therapy Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Distribution Channel
    • 6.3.2. Canada Nicotine Replacement Therapy Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Distribution Channel
    • 6.3.3. Mexico Nicotine Replacement Therapy Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Distribution Channel

7. Europe Nicotine Replacement Therapy Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Distribution Channel
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Nicotine Replacement Therapy Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Distribution Channel
    • 7.3.2. United Kingdom Nicotine Replacement Therapy Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Distribution Channel
    • 7.3.3. Italy Nicotine Replacement Therapy Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Distribution Channel
    • 7.3.4. France Nicotine Replacement Therapy Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Distribution Channel
    • 7.3.5. Spain Nicotine Replacement Therapy Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Distribution Channel

8. Asia-Pacific Nicotine Replacement Therapy Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Distribution Channel
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Nicotine Replacement Therapy Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Distribution Channel
    • 8.3.2. India Nicotine Replacement Therapy Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Distribution Channel
    • 8.3.3. Japan Nicotine Replacement Therapy Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Distribution Channel
    • 8.3.4. South Korea Nicotine Replacement Therapy Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Distribution Channel
    • 8.3.5. Australia Nicotine Replacement Therapy Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Distribution Channel

9. South America Nicotine Replacement Therapy Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Distribution Channel
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Nicotine Replacement Therapy Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Distribution Channel
    • 9.3.2. Argentina Nicotine Replacement Therapy Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Distribution Channel
    • 9.3.3. Colombia Nicotine Replacement Therapy Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Distribution Channel

10. Middle East and Africa Nicotine Replacement Therapy Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Distribution Channel
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Nicotine Replacement Therapy Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Distribution Channel
    • 10.3.2. Saudi Arabia Nicotine Replacement Therapy Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Distribution Channel
    • 10.3.3. UAE Nicotine Replacement Therapy Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Nicotine Replacement Therapy Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Cipla Inc.
    • 14.1.1. Business Overview
    • 14.1.2. Product & Service Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (If Listed)
    • 14.1.5. Key Personnel
    • 14.1.6. SWOT Analysis
  • 14.2. Pfizer Inc.
  • 14.3. Johnson & Johnson Services, Inc.
  • 14.4. Philip Morris Products S.A
  • 14.5. British American Tobacco p.l.c.
  • 14.6. Japan Tobacco, Inc.
  • 14.7. Imperial Brands PLC
  • 14.8. Glenmark Ltd

15. Strategic Recommendations

16. About Us & Disclaimer